title: A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax.
authors.affiliation: Department of Clinical Pharmacology, King Edward Memorial Hospital, Parel, Mumbai, India.
authors.forename: N
authors.initials: N
authors.lastname: Gogtay
authors.forename: M
authors.initials: M
authors.lastname: Garg
authors.forename: V
authors.initials: V
authors.lastname: Kadam
authors.forename: K
authors.initials: K
authors.lastname: Kamtekar
authors.forename: N A
authors.initials: NA
authors.lastname: Kshirsagar
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D016780:Malaria, Vivax / Q000188:drug therapy* / Q000517:prevention & control; D011319:Primaquine / Q000627:therapeutic use*; D055502:Secondary Prevention
chemical_list: D000962:Antimalarials; D002738:Chloroquine; D011319:Primaquine